EUCTR2010-021369-66-DE进行中（未招募）不适用
Investigation of pharmacokinetics of Ciprofloxacin and Piperacillin/Tazobactam in Patients receiving continuous renal replacement therapy
Department of Pharmacy Universitaetsmedizin Mainz0 个研究点目标入组 40 人开始时间: 2010年9月28日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Written consent to the clinical trial by the patient or the legal representative
- •Continuous renal replacement therapy
- •Antibiotic treatment with piperacillin/tazobactam and/or ciprofloxacin
- •Every patient has to be older than 18 years
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Unreadiness to the clinical trial
- •No antibiotic treatment with piperacillin/tazobactam and/or ciprofloxacin
- •No continuous renal replacement therapy
- •Not older than 18 years
- •Other clinical trial
研究者
相似试验
已完成
不适用
To study ciprofloxacin pharmacokinetics in patients who are critically ill and undergoing continuous dialysisPatients on dialysisNutritional, Metabolic, EndocrineRenal failureISRCTN52722850Trinity College Dublin (Ireland)7
已完成
不适用
A study of the concentration of ciprofloxacin in the body over time when given by mouthSevere acute malnutritionNutritional, Metabolic, EndocrineUnspecified protein-energy malnutritionISRCTN31079753Kenya Medical Research Institute (KEMRI) Wellcome Trust Research Programme (Kenya)52
已完成
4 期
Examining whether any interactions occur between the antibiotic Ciprofloxacin and the antimalarial treatment Chloroquine/ProguanilPharmacokineticsISRCTN20647977Defence Science and Technology Laboratory (Dstl)16
进行中（未招募）
1 期
Pharmacokinetic Interactions between Ciprofloxacin and Chloroquine / Proguanil ProphylaxisChloroquine/proguanil is used for malaria chemoprophylaxis in areas where chloroquine-resistant Plasmodium falciparum malaria is prevalent, except in regions of Africa where chloroquine/proguanil is no longer effective. Ciprofloxacin is a fluoroquinolone antibiotic used to treat a wide variety of infections, such as traveller`s diarrhoea. Only healthy subjects will be treated in this study.EUCTR2005-004905-27-GBDstl16
已完成
4 期
Ciprofloxacin pharmacokinetics after IV and oral administration in cachectic elderly patients10004018PneumoniacystitisUrinary tract infectionNL-OMON50150Tergooiziekenhuizen25